Dr. Mikhael is a Professor in the Clinical Genomics and Therapeutics Division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He also is the Chief Medical Officer of the International Myeloma Foundation (IMF) and Director of Myeloma research at the HonorHealth Research Institute. He also serves as the Treasurer on the executive panel of the American Society of Hematology.
Dr. Mikhael has published over 200 peer-reviewed articles in these fields and lectures internationally on a regular basis. Dr. Mikhael is deeply committed to health disparities in myeloma and leads the diversity efforts of the IMF, namely the M-Power project in the African American community. He also is chair of the Diversity, Equity and Inclusion Council at TGen.
Dr. Mikhael is heavily involved in training future researchers and mentors junior faculty worldwide. He also spends nearly 20% of his time in the third world, developing collaborations in myeloma and finding ways to enhance access to novel agents.